Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapies
Author:
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Link
https://link.springer.com/content/pdf/10.1007/s00296-022-05163-8.pdf
Reference32 articles.
1. Felson DT, Smolen JS, Wells G et al (2011) American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 70:404–413. https://doi.org/10.1136/ard.2011.149765
2. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP (2008) Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 117(2):244–279. https://doi.org/10.1016/j.pharmthera.2007.10.001
3. Wells AF, Curtis JR, Betts KA, Douglas K, Du Xiaoyan E, Ganguli A (2017) Systematic literature review and meta-analysis of tumor necrosis factor-alpha experienced rheumatoid arthritis. Clin Ther 39(8):1680-1694.e2. https://doi.org/10.1016/j.clinthera.2017.06.013
4. Boyadzhieva V, Stoilov N, Ivanova M, Petrova G, Stoilov R (2018) Real world experience of disease activity in patients with rheumatoid arthritis and response to treatment with varios biologic DMARDs. Front Pharmacol 9:1303. https://doi.org/10.3389/fphar.2018.01303
5. Boyadzieva VV, Stoilov N, Stoilov RM, Tachkov K, Kamusheva M, Mitov K, Petrova GI (2018) Quality of life and cost study of rheumatoid arthritis therapy with biological medicines. Front Pharmacol 9:794. https://doi.org/10.3389/fphar.2018.00794.eCollection2018
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. IGF2BP3 regulates the expression of RRM2 and promotes the progression of rheumatoid arthritis via RRM2/Akt/MMP-9 pathway;PLOS ONE;2024-05-31
2. The novel delivery-exosome application for diagnosis and treatment of rheumatoid arthritis;Pathology - Research and Practice;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3